#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial germ cell tumour Plasma cell myeloma refractory Nephrotic syndrome Metastases to central nervous system Severe myoclonic epilepsy of infancy Sickle cell disease Peritoneal mesothelioma malignant Hepatocellular carcinoma Diffuse large B-cell lymphoma refractory Emphysema Cystic fibrosis lung Diffuse large B-cell lymphoma recurrent Hereditary angioedema with C1 esterase inhibitor deficiency Osteosarcoma recurrent Cholangitis sclerosing More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Basic Information IgA nephropathy – Life with Disease Hepatic angiosarcoma – Basic Information Splenic marginal zone lymphoma – Treatment Uterine leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Treatment Haemophilia A with anti factor VIII Biotinidase deficiency – Life with Disease Haemophilia B without inhibitors – Life with Disease Choroid melanoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dutasteride RP3 Corline Heparin Conjugate Betibeglogene Autotemcel Farletuzumab Ecteribulin Quizartinib Dihydrochloride Metamizole Fosinopril Sodium Tipranavir 11902A Pc14586 Prednisolone Sodium Succinate Immunoglobulins, Normal Human AZD3632 Leflunomide Glyceryl Trinitrate Radotinib Dihydrochloride Midomafetamine Hydrochloride GSKVX000000030918 Envudeucitinib More therapies…

    Learn about Your Condition

    Urea cycle disorder Muscle spasticity Burning mouth syndrome Carotid artery occlusion Ischaemic skin ulcer Breast cancer in situ Arterial stiffness Endometrial cancer Delirium Lipid metabolism disorder Gaucher's disease type III Chronic disease Leukocyte adhesion deficiency Psychogenic seizure Embolism venous More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ziftomenib
    • Fludarabine Phosphate
    • Cytarabine
    Austria France Italy The Netherlands Spain

  • Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Berotralstat
    Czechia France Germany Italy Poland Slovakia +1

  • Study on the Safety and Effectiveness of OC-1 Therapy for Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
    Spain

  • Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Zanubrutinib
    • Obinutuzumab
    Belgium France

  • Study on Acalabrutinib for Adults with Chronic Lymphocytic Leukemia and Heart Issues

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    Czechia Italy Poland Spain

  • Study on the Effectiveness of Apixaban for Pain Relief in Patients with Venous Malformations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriovenous malformation
    Investigated Drugs:
    • Apixaban
    Norway
Previous Page
1 … 14 15 16 17 18 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!